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Reconstructive trends and complications
following parotidectomy: incidence and
predictors in 11,057 cases
Cory Donovan Bovenzi* , Peter Ciolek, Meghan Crippen, Joseph M. Curry, Howard Krein and Ryan Heffelfinger
Abstract
Background: Parotidectomy is a common treatment option for parotid neoplasms and the complications associated
with this procedure can cause significant morbidity. Reconstruction following parotidectomy is utilized to address
contour deformity and facial nerve paralysis. This study aims to demonstrate national trends in parotidectomy patients
and identify factors associated with adverse postoperative outcomes. This study includes the largest patient database
to date in determining epidemiologic trends, reconstructive trends, and prevalence of adverse events following
parotidectomy.
Methods: A retrospective review was performed for parotidectomies included in the ACS-NSQIP database between
January 2012 and December 2017. CPT codes were used to identify the primary and secondary procedures performed.
Univariate and multivariate analysis was utilized to determine associations between pre- and perioperative variables
with patient outcomes. Preoperative demographics, surgical indications, and common medical comorbidities were
collected. CPT codes were used to identify patients who underwent parotidectomy with or without reconstruction.
These pre- and perioperative characteristics were compared with 30-day surgical complications, medical complications,
reoperation, and readmission using uni- and multivariate analyses to determine predictors of adverse events.
Results: There were 11,057 patients who underwent parotidectomy. Postoperative complications within 30 days were
uncommon (1.7% medical, 3.8% surgical), with the majority of these being surgical site infection (2.7%). Free flap
reconstruction, COPD, bleeding disorders, smoking, and presence of malignant tumor were the strongest independent
predictors of surgical site infection. Readmission and reoperation were uncommon at an incidence of 2.1% each. The
strongest factors predictive of readmission were malignant tumor and corticosteroid usage. The strongest factors
predictive of reoperation were free flap reconstruction, malignant tumor, bleeding disorder, and disseminated cancer.
Surgical volume/contour reconstruction was relatively uncommon (18%). Facial nerve sacrifice was uncommon (3.7%)
and, of these cases, only 25.5% underwent facial nerve reinnervation and 24.0% underwent facial reanimation.
Conclusions: There are overall low rates of complications, readmissions, and reoperations following parotidectomy.
However, certain factors are predictive of adverse postoperative events and this data may serve to guide management
and counseling of patients undergoing parotidectomy. Concurrent reconstructive procedures are not commonly
reported which may be due to underutilization or underreporting.
Keywords: Parotidectomy, Complications, Facial nerve, NSQIP, Reconstruction, Epidemiology, Readmission, Contour,
Comorbidities, Infection
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Background
Parotid neoplasms are rare entities which comprise less
than 3% of head and neck tumors. Management is primar-
ily surgical, and depending on the extent and severity of
disease, ranges from a superficial parotidectomy to a rad-
ical parotidectomy with facial nerve sacrifice [1]. There is
ample data pertaining to site specific morbidity following
parotidectomy (e.g. facial nerve weakness, salivary fistula,
and Frey’s syndrome); however, the literature on general
postoperative surgical morbidity following parotidectomy
is lacking [2].
In the era of quality metrics, there is an ever-growing
focus on improving surgical and postsurgical care, while
reducing complications and cost. In 2001, The American
College of Surgeons (ACS) piloted the first iteration of the
National Surgical Quality Improvement Program (NSQIP)
in the private hospital sector. The NSQIP database collects
over 130 patient variable including preoperative risk fac-
tors, intraoperative variables, and postoperative complica-
tions. This data can be used by hospitals to track, analyze,
and compare the quality of surgical care in a risk-adjusted
manner. Currently, over 700 hospitals including 8 of the
top 10 hospitals as ranked by the US News & world report
participate in the program [3, 4].
Currently, the majority of literature pertaining to the
outcomes and trends in parotidectomy are limited to
single institution or small multi-institutional studies.
Our investigation aims to provide a reference for na-
tional trends in parotidectomy surgery including patient
demographics, pre-operative comorbidities, operative
variables, and postoperative outcomes.
Methods
Data and study cohort
This is a retrospective analysis of the parotidectomy cases
using the NSQIP participant user files from January 2012
through December 2017. The database was queried for all
cases with the following Current Procedural Terminology
(CPT) codes: 42410, 42,415, 42,420, 42,425, and 42,426.
The resultant cohort was characterized by rates of patient
characteristics, comorbidities, operative characteristics,
and 30-day postoperative complications.
Patient characteristics
Patient demographics examined included age, sex, and
race. The indication for parotidectomy was elicited using
the International Classification of Disease (ICD) version 9
or 10 code given for postoperative diagnosis and grouped
into five major categories: malignant tumor, benign
tumor, tumor not otherwise specified (NOS), other disease
of parotid, and unclassified (Additional file 1 Table S1).
Comorbidities defined by NSQIP include smoking (within
the year prior to admission), weight loss (> 10% body
weight in the 6months prior to surgery), hypertension
(requiring medication), dyspnea (on exertion or at rest),
corticosteroid use (< 30 days prior to surgery), surgical site
infection, non-independent functional status, and a num-
ber of additional preexisting medical conditions [5]. Obes-
ity was defined as BMI (body mass index) > 30, derived
from height and weight variables.
Operative characteristics
Cases were further analyzed for operative characteristics.
Variables including inpatient versus outpatient status, sur-
gical specialty performing the parotidectomy (otolaryngol-
ogy- head and neck surgery, general surgery, plastic
surgery, and other), and total operative time were directly
defined by NSQIP [5]. The principal parotidectomy CPT
code was used to determine procedure extent (total vs.
superficial) and management of the facial nerve (not dis-
sected, dissected and preserved, sacrificed, and unknown).
Additionally using CPT codes, rates of concurrent proce-
dures were examined such as neck dissection, nerve moni-
toring, free flap, other volume restoration, reinnervation,
and reanimation. Procedure type and associated CPT
codes are given in Additional file 1 Table S1.
Outcome variables
Operative outcomes were assessed including rates of 30-
day surgical complications, medical complications, reopera-
tion, readmission, and length of hospital stay. Specific surgi-
cal complications include superficial surgical site infection
(SSI), deep SSI (defined as “deep” or “organ space” SSI),
wound dehiscence, and hemorrhage/hematoma formation.
Specific medical complications include cardiac arrest, myo-
cardial infarction, stroke, ventilator requirement > 48 h,
pneumonia, and various others enumerated in Table 3.
All complication variables were coded by NSQIP [5]
with the exception of hemorrhage/hematoma, which was
derived from the relevant ICD-9 and 10 codes given for
readmission or reoperation diagnosis (Additional file 1
Table S1). The occurrence of this complication therefore
refers to cases requiring reoperation or readmission for
postoperative hemorrhage or hematoma formation
within 30 days of the principal procedure.
Statistical analysis
Descriptive statistics were used to summarize by rates of
patient characteristics, comorbidities, operative charac-
teristics, and 30-day postoperative complications across
the study cohort. In order to identify the patient and
procedure characteristics associated with an increased
risk for postoperative morbidity, binary logistic regres-
sion was performed. A regression model was generated
to account for patient demographics, comorbidities, pro-
cedure extent, indication, setting, surgical specialty, and
concurrent procedures. All comorbidities occurring at a
rate of ≥0.5% of the overall cohort were included. Cases
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with unknown values were excluded, leaving 8811 cases
for analysis. Regression analysis was performed for each
complication occurring at a rate of ≥0.5%, including
wound dehiscence, surgical site infection, hemorrhage/
hematoma, overall surgical and medical complications,
readmission, and reoperation. All variables found to be
significantly associated with each of these complications
are listed in Table 4.
All statistical analyses were performed using SPSS
(Statistical Package for the Social Sciences), version 23
(IBM, Armok, NY). P-values of < 0.05 were considered
to be statistically significant. This analysis was deter-
mined to be exempt from Institutional Review Board ap-
proval due to the de-identified nature of the dataset.
Results
A total of 11,057 patients were identified as having
undergoing parotidectomy between January 1, 2012 and
December 31, 2017. Of these patients, the majority were
male (53.0%), white (70.4%), and ages 61–70 (26.6%). In
this cohort, parotidectomy was most commonly per-
formed for benign neoplasms (45.2%), followed by malig-
nant neoplasms (29.7%) and tumors of uncertain
significance (13.0%). Parotidectomy was indicated for
non-neoplastic disease (e.g. chronic parotitis) in 8.8% of
cases. Examination of various patient comorbidities
found hypertension (45.4%), obesity (39.7%), and smok-
ing (23.5%) to be most common (Table 1). Patients
undergoing parotidectomy for benign lesions were sig-
nificantly more likely to be smokers compared to those
undergoing parotidectomy for malignant lesions (30.5%
vs. 13.9%, p < 0.001). This may represent a preponder-
ance of Warthin’s tumors in smokers.
In this cohort, superficial parotidectomy was per-
formed 2.4 times more frequently than total parotidect-
omy. Concurrent neck dissection was performed in
19.9% of cases. Reconstruction involving volume restor-
ation was performed in 12.4% of cases, including free
flaps (3.6%), local flaps (5.4%), fat/dermal grafts (2.0%),
and allografts (1.8%) (Table 2). Total parotidectomy
cases were significantly more likely to involve a concur-
rent volume restoration procedure compared to superfi-
cial parotidectomy (17.8% vs. 10.3%, p < 0.001). Facial
nerve sacrifice was recorded in 3.7% of cases (Table 2).
In this subset of patients, 25.5% underwent a concurrent
reinnervation procedure, and 24.0% underwent a con-
current reanimation procedure (Table 2).
Overall, 5.1% of patients experienced a postoperative
complication within 30 days of the procedure. The major-
ity were surgical complications, occurring in 3.8% of pa-
tients. Surgical site infection occurred most commonly,
with 1.9% developing a superficial SSI, and 0.8% of pa-
tients developing a deep SSI. Unplanned reoperation was
observed in 2.1% of cases. Medical complications occurred
in 1.7% of patients, the most common of these being
pneumonia (0.4%) and urinary tract infection (0.4%). The
mean length of stay was 1.65 days with an unplanned 30-
day readmission rate of 2.1% (Table 3). On binary logistic
Table 1 Demographics and Patient Characteristics
N %
Age
< 50 2772 25.3
51–60 2389 21.6
61–70 2920 26.6
71–80 1977 18.0
> 80 902 8.2
Sex
Male 5862 53.0
Female 5195 47.0
Race
White 7784 70.4
Black 713 6.4
Other 703 6.4
Unknown 1857 16.8
Surgical Indication
Malignant tumor 3288 29.7
Benign tumor 4995 45.2
Tumor Not Otherwise Specified 1433 13.0
Other disease of parotid 977 8.8
Other/unknown 364 3.3
Comorbidities
Bleeding disorder 248 2.2
Diabetes 1707 15.4
On dialysis 39 0.4
Disseminated cancer 364 3.3
Dyspnea 536 4.8
Dependent functional status 129 1.2
Congestive Heart Failure 29 0.3
Chronic Obstructive Pulmonary Disease 518 4.7
Hypertension 5019 45.4
Obesity (BMI > 30) 3857 39.7
Smoker 2602 23.5
Corticosteroids 363 3.3
Wound infection 155 1.4
Weight loss 68 0.6
ASA class
1 (No disturbance) 990 9.0
2 (Mild disturbance) 5355 48.5
3 (Severe disturbance) 4395 39.8
4 (Life threatening) 307 2.8
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regression, various patient and procedure related charac-
teristics were found to be independently associated with
an increased risk of medical and surgical complications.
Of the demographic variables assessed, increasing age was
found to be significantly associated with increasing risk
for overall medical complications but was not associated
with surgical complications (Additional file 2 Table S2).
Relative to those with a benign neoplasm, patients
undergoing parotidectomy for a malignant neoplasm were
found to be at significantly higher risk for overall surgical
and medical complications as well as reoperation and re-
admission (Additional file 2 Table S1). Both smoking and
COPD (chronic obstructive pulmonary disease) were inde-
pendently predictive of wound dehiscence and surgical
site infection. Of the concurrent procedures examined,
only volume restoration procedures were predictive of
surgical complications. Free flap procedures were inde-
pendently associated with the highest risk for overall sur-
gical complications with an odds ratio of 2.87 (Table 4).
Neck dissection, reanimation, and reinnervation proce-
dures were not found to significantly increase risk for any
measure of postoperative morbidity (Table 5).
SSI = surgical site infection, SD = standard deviation.
Discussion
To date, this is the most robust dataset to evaluate national
trends in parotidectomy surgery. The post-parotidectomy
complication rates seen here are the most substantial infor-
mation available to counsel patients with, and are the most
thorough and recent data available thus far. There has been
a review of the NSQIP data from 2006 to 2011 which evalu-
ated 2919 patients which also reported low rates of medical
and surgical complications [6]. In addition to evaluating a
newer and larger dataset, the current study is likely to be of
increased validity, as NSQIP removed several unreliable
outcomes variables from the dataset in 2012 [5]. The data
here correspond to existing literature that post-
parotidectomy medical and surgical complications increase
with increasing age [7, 8]. However, the rate of surgical site
complications seen here are lower than that of those re-
ported in some single-center studies [9], which highlights
the institutional differences in complication rates, and the
national average estimated with this study may become an
important standard for quality of care assessments at an in-
stitutional level. The difference in complication rates is an
important feature for further investigation as comparison of
Table 2 Operative Characteristics
Non-Reconstructive Operative Characteristics
N %
Parotidectomy extent
Total 3229 29.2
Superficial 7828 70.8
Management of facial nerve
Not dissected 1683 15.2
Dissected and preserved 8575 77.6
Sacrificed 405 3.7
Unknown 394 3.6
Concurrent procedures
Neck dissection 2204 19.9
Nerve monitoring 263 2.4
Surgeon specialty
Otolaryngology 10,094 91.3
General Surgery 745 6.7
Plastic Surgery 180 1.6
Other 38 0.3
Setting
Inpatient 4130 37.4
Outpatient 6927 62.6
Operative time, mean [SD] (min) 185.3 [141.9]
Utilization of Reconstructive Procedures
N %
Free flap 393 3.6
Other volume restoration 998 9.0
Reinnervation 205 1.9
Reanimation 124 1.1
Table 3 Complication Rates Following Parotidectomy
N %
Medical Complications, Overall 186 1.7
Cardiac arrest 13 0.1
Myocardial Infarction 22 0.2
Stroke 24 0.2
Reintubation 35 0.3
Ventilator-dependent > 48 h 27 0.2
Sepsis/septic shock 33 0.3
Pneumonia 49 0.4
Pulmonary Embolism 13 0.1
Acute Kidney Injury 14 0.1
Urinary Tract Infection 43 0.4
Deep Vein Thrombosis 20 0.2
Surgical Complications, Overall 418 3.8
Wound disruption 50 0.5
Superficial SSI 209 1.9
Deep SSI 84 0.8
Hemorrhage/Hematoma 100 0.9
Unplanned Readmission 236 2.1
Unplanned Reoperation 234 2.1
Length of Stay, mean [SD] (days) 1.65 [4.00]
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quality of care becomes increasingly important. While one
may assume that high volume centers would have lower
complication rates, in parotidectomy for benign disease, a
previous study has shown that surgeon experience did not
seem to be associated with complication rates- however, at
that institution they admit that more complicated cases
were reserved for more experienced surgeons [10].
There is a significant body of research available evaluating
single-site experiences with common complications after
parotidectomy. These studies are mostly limited to facial
paresis, Frey syndrome, hypoesthesia, and contour deform-
ity. Unfortunately, this dataset did not capture these com-
plications. However, there is evidence that parotidectomy
reconstructive techniques may mitigate some of these ad-
verse outcomes.
Facial paresis following parotidectomy is a common
finding that is typically self-limiting and limited to mar-
ginal mandibular nerve weakness [11]. This risk may be
mitigated by performing a limited surgical approach
[12–14], or if there is reconstruction with a muscular
flap, with or without an abdominal fat graft [15, 16]. Frey
syndrome is a historically common complication follow-
ing parotidectomy described as gustatory sweating due
to aberrant reinnervation of secretory parasympathetic
fibers from parotid tissue to dermal tissue. Reconstruct-
ive procedures that provide a barrier between parotid
tissue and the dermal surface have been shown to de-
crease the incidence of Frey Syndrome [15, 17–20].
These reconstructions include rotating a sternocleido-
mastoid flap into the defect, elevating a superficial mus-
culoaponeurotic flap prior to performing parotidectomy,
grafting free abdominal fat, and insertion of acellular
Table 4 Multivariable Logistic Regression of Adverse Events
Following Parotidectomy, Significant Variables
OR 95% CI p
Surgical site infection
Male 1.41 1.01–1.96 0.042
Bleeding disorder 2.21 1.20–4.07 0.011
Diabetes 1.66 1.17–2.37 0.005
COPD 2.08 1.25–3.45 0.005
Hypertension 1.53 1.08–2.16 0.017
Smoking 1.85 1.32–2.59 < 0.001
Malignant tumor 1.70 1.09–2.67 0.021
Free flap reconstruction 2.87 1.67–4.93 < 0.001
Other volume restoration 1.66 1.07–2.57 0.025
Wound Dehiscence
COPD 2.65 1.03–6.87 0.044
Smoking 2.58 1.23–4.34 0.013
Malignant tumor 4.33 1.36–13.77 0.013
Other disease of parotid 5.31 1.51–18.71 0.009
Free flap reconstruction 3.25 1.39–7.58 0.006
Other volume restoration 3.39 1.60–7.19 0.001
Hematoma/seroma
Free flap reconstruction 3.13 1.43–6.83 0.004
Readmission
Disseminated cancer 2.02 1.30–3.15 0.002
Hypertension 1.44 1.05–1.97 0.023
Corticosteroids 2.62 1.69–4.07 < 0.001
Wound infection 2.07 1.10–3.90 0.025
Malignant tumor 3.00 1.94–4.65 < 0.001
Other disease of parotid 2.21 1.31–3.75 0.003
Reoperation
Bleeding disorder 1.82 1.02–3.26 0.044
Disseminated cancer 1.66 1.01–2.71 0.044
Malignant tumor 2.64 1.65–4.20 < 0.001
Free flap reconstruction 3.56 2.30–5.50 < 0.001
OR = odds ratio, CI = confidence interval.
Table 5 Multivariable Logistic Regression of Adverse Events
Following Parotidectomy: Odds Ratios Associated with
Reconstructive Procedures
OR 95% CI p
Surgical site infection
Free flap reconstruction 2.87 1.67–4.93 < 0.001
Other volume restoration 1.66 1.07–2.57 0.025
Reinnervation 0.93 0.42–2.22 0.961
Reanimation 0.94 0.35–2.62 0.959
Wound Dehiscence
Free flap reconstruction 3.25 1.39–7.58 0.006
Other volume restoration 3.39 1.60–7.19 0.001
Reinnervation 0.47 0.12–2.66 0.563
Reanimation 1.90 0.50–7.25 0.350
Hemorrhage/Hematoma
Free flap reconstruction 3.13 1.43–6.83 0.004
Other volume restoration 1.02 0.46–2.27 0.962
Reinnervation 0.42 0.12–2.46 0.537
Reanimation 2.11 0.63–7.05 0.227
Readmission
Free flap reconstruction 1.29 0.72–2.32 0.399
Other volume restoration 1.24 0.79–1.97 0.353
Reinnervation 0.72 0.28–1.86 0.493
Reanimation 1.18 0.44–3.18 0.749
Reoperation
Free flap reconstruction 3.56 2.30–5.50 < 0.001
Other volume restoration 1.50 0.95–2.38 0.083
Reinnervation 1.03 0.51–2.07 0.937
Reanimation 1.30 0.62–2.72 0.481
OR = odds ratio, CI = confidence interval.
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dermis. There is continued debate on the most effective
reconstruction method. A meta-analysis on the subject
suggests that all of the above interventions decrease Frey
syndrome but acellular dermis implants may be associ-
ated with higher infection rates [14].
These reconstruction options also help improve post-
operative facial symmetry, especially in cases of total
parotidectomy. Parotidectomy, as a common procedure
performed in a highly cosmetic region is uniquely poised
to benefit from advances in maintaining symmetric vol-
ume and minimizing visible scarring. Adequate exposure
and improved scar cosmesis has been shown to follow
from the trend of utilizing a facelift incision in paroti-
dectomy [21, 22]. Following large parotidectomy defects
encountered in total parotidectomy and radical paroti-
dectomy, muscular flaps and fat grafting have shown to
reduce contour asymmetry [16, 22, 23]. Additionally, an-
other level of complexity occurs when parotidectomy re-
quires concurrent skin and/ or facial nerve sacrifice
which typically is necessary in cases of malignant lesions
with adjacent tumor invasion. Fortunately, multiple re-
constructive options exist for these defects- for skin and
soft tissue reconstruction, anterolateral thigh free flaps
have been the mainstay of treatment due to the large
vessel caliber available for microvascular anastomosis
and variable size and shape available with this option
[24–27]. Additionally, if the patient requires postopera-
tive radiation, the volume of this free flap after radical
parotidectomy reconstruction has been shown to be re-
duced by only 8% [28]. Other options available for free
flap reconstruction include latissimus dorsi free flap and
superficial inferior epigastric artery free flap [29]. How-
ever, the latissimus dorsi free flap is more difficult to
harvest concurrently and is likely to result in higher
postoperative donor site morbidity. The superficial infer-
ior epigastric artery free flap has much smaller caliber
vessels which may increase risk of flap failure and de-
crease ability for postoperative flap monitoring. For cases
with facial nerve sacrifice, it is surprising that only 25.5%
of patients have documented reinnervation procedures,
and only 24% have documented reanimation procedures
(Table 2). This low rate of facial reinnervation and reani-
mation following radical parotidectomy is also under-
scored in a recent review of NSQIP [30]. This leads to
the question of whether these procedures fail to be
coded and thus detected by the database or whether
these procedures are truly not performed commonly in
cases with facial nerve sacrifice. There is encouraging
data that would encourage immediate reinnervation and
reanimation in these cases [31].
Surgical site infection following parotidectomy is not a
well-researched complication, likely due to its low inci-
dence. Our study showed an incidence of 2.7%, with the
highest predictors of SSI being concurrent free flap and
pre-existing bleeding disorder. This would provide evi-
dence that the mechanism for post-parotidectomy
wound infections is from hematoma formation that
becomes subsequently infected. Following this logic, as
post-parotidectomy hematomas are more common in
males due to rich blood supply of hair follicles in the
overlying dermis, it is not surprising that males were
also found to have significantly increased risk for devel-
oping SSI compared to females. In fact, in the literature,
there been an association with drain output greater than
50ml in 24 h to be predictive of surgical site infection
[32, 33]. Since abdominal fat grafts have also been
shown to be associated with increased surgical site
drainage [20] and larger defects are more likely to
prompt contour adjustments, it is concordant that vol-
ume restoration was associated with a higher rate of SSIs
in our dataset (Table 4).
Poor wound-healing may also contribute to SSI and
wound dehiscence and this process may be exacerbated by
the systemic factors seen to increase risk for both of these
outcomes in this study. These factors include comorbid
COPD, diabetes, and a smoking history. These results
contradict a recent single-center study which did not find
an association with diabetic status and post-parotidectomy
surgical site infection [34]. However, they are consistent
with previous data on smoking increasing surgical compli-
cation risk following parotidectomy [6]. Many institutions,
including our own, preoperatively counsel patients on the
importance of smoking cessation prior to parotidectomy
and this study provides substantiated data to help further
justify and aid this counseling process.
Medical complications that do not involve the surgical
site are not well-studied and the data provided here
point towards a relatively low incidence of these adverse
outcomes. These complications appear to be associated
with advanced age, malignancy, weight loss, wound in-
fection, concomitant corticosteroid use, free flap recon-
struction, and undergoing surgery in an inpatient setting
(Additional file 2 Table S2). These associated factors are
unsurprising as older patients and those who have ma-
lignancy or require free flap reconstruction would be ex-
pected to be at an elevated risk preoperatively and those
with a higher ASA (American Society of Anesthesiolo-
gists) physical status level would be more likely to have
their surgery performed at a hospital-based setting.
Limitations
This study is subject to several limitations inherent to
the use of a large national database. The most notable of
these is the absence of procedure-specific outcomes such
as facial nerve paresis and the inability to assess compli-
cations beyond the 30-day postoperative period. There is
also the issue of procedures that are not coded correctly.
For example, in this dataset, facial nerve monitoring was
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only coded in 2.4% of cases, despite this being a routine
aspect of parotidectomy and is considered by many sur-
geons to be the standard of care. The small incidence of
facial nerve monitoring in this study is likely due to lack
of proper documentation and exemplifies a fundamental
limitation of using this retrospective dataset. Further, the
possibility of confounding cannot be excluded given the
absence of disease-specific variables such as tumor stage.
However, the data captured by NSQIP has been shown
to be of high validity, particularly when compared to
comparable population datasets derived from adminis-
trative claims data [35]. The method of data collection is
worth noting, as NSQIP is unique in utilizing trained
clinical reviewers to extract data from the medical rec-
ord. As a result, NSQIP data has been shown to capture
61% more complications than comparable population
datasets derived from administrative claims data [35].
However, this method of data collection may in part ex-
plain the lower than expected rate of concurrent proce-
dures such as nerve monitoring, as the associated CPT
code may not have been clearly documented in the med-
ical record. While the strength of this analysis lies in the
statistical power afforded by the NSQIP database, these
results should be interpreted with these limitations in
mind.
Conclusions
As the US health care system moves towards a quality-
based outcome model, the information available in this
data set regarding readmission and reoperation rates are
of importance for risk-stratification of these patients.
Not only surgeons, but hospital administrators will be
interested in readmission rates for this relatively safe
procedure. Thus, being aware of these variables (Table
4) may help with patient selection for inpatient versus
outpatient surgery as well as frequency and duration of
follow up for patients with these identified risk factors.
Further study is necessary to determine the cause of re-
admission and reoperation for these patients and
whether these readmissions are avoidable.
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